Literature DB >> 12907343

Metabolic and anthropometric evaluation of insulin resistance in nondiabetic patients with nonalcoholic steatohepatitis.

Naga Chalasani1, Mark A Deeg, Scott Persohn, David W Crabb.   

Abstract

OBJECTIVES: Insulin resistance is nearly universal in patients with nonalcoholic steatohepatitis (NASH) when tested by glucose tolerance tests or clamp methods. However, the pattern of insulin resistance in these patients after a physiological challenge is unknown. We conducted a study to characterize the metabolic response to a mixed meal in nondiabetic patients with NASH (NDN) and to identify anthropometric determinants of insulin resistance in these patients.
METHODS: Serum insulin, C-peptide, glucose, and free fatty acid (FFA) levels were measured at 0, 30, 60, 90, and 120 min after a 500-kcal standard meal in 18 NDN and 18 age-, gender-, and body mass index (BMI)-matched controls. Correlations were made between insulin resistance and various anthropometric, calorimetric, and serological variables.
RESULTS: Compared with controls, NDN had significantly higher levels of insulin and C-peptide at baseline and after the mixed meal. However, glucose levels were not different either at baseline or after the meal. NDN had higher fasting levels of FFA than the controls (459 +/- 190 vs 339 +/- 144 micro mol/L, respectively, p = 0.03); however, meal-induced suppression in lipolysis was similar between the two groups (39 +/- 113% vs 46 +/- 60%, p = 0.8). Insulin resistance was significantly correlated with BMI (r = 0.39, p = 0.02) and visceral fat (r = 0.50, p = 0.004). Whereas BMI, percent total body fat, and subcutaneous abdominal fat were similar between the groups, the NASH group had significantly higher percent visceral fat compared with controls (28 +/- 10% vs 22 +/- 14%, p = 0.02).
CONCLUSIONS: NDN are significantly hyperinsulinemic, both at fasting and after the mixed meal; however, their glucose homeostasis and suppression in lipolysis after a meal challenge are maintained. Insulin resistance in these patients is likely related to their higher visceral fat mass.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12907343     DOI: 10.1111/j.1572-0241.2003.07619.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  11 in total

Review 1.  Cytokines and the pathogenesis of non-alcoholic steatohepatitis.

Authors:  A M Diehl; Z P Li; H Z Lin; S Q Yang
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

2.  Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects.

Authors:  H B Holt; S H Wild; P J Wood; J Zhang; A A Darekar; K Dewbury; R B Poole; R I G Holt; D I Phillips; C D Byrne
Journal:  Diabetologia       Date:  2005-12-02       Impact factor: 10.122

3.  Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease.

Authors:  Lauren N Bell; Janice L Theodorakis; Raj Vuppalanchi; Romil Saxena; Kerry G Bemis; Mu Wang; Naga Chalasani
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

4.  Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.

Authors:  E Bugianesi; A Gastaldelli; E Vanni; R Gambino; M Cassader; S Baldi; V Ponti; G Pagano; E Ferrannini; M Rizzetto
Journal:  Diabetologia       Date:  2005-03-04       Impact factor: 10.122

5.  Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome.

Authors:  Jun Seok Lee; Sang Heum Kim; Dae Won Jun; Jee Hye Han; Eun Chul Jang; Ji Young Park; Byung Kwan Son; Seong Hwan Kim; Yoon Ju Jo; Young Sook Park; Yong Soo Kim
Journal:  World J Gastroenterol       Date:  2009-04-21       Impact factor: 5.742

6.  Liver steatosis, but not fibrosis, is associated with insulin resistance in nonalcoholic fatty liver disease.

Authors:  Masaru Sakurai; Toshinari Takamura; Tsuguhito Ota; Hitoshi Ando; Hiroshi Akahori; Kyosuke Kaji; Motoko Sasaki; Yasuni Nakanuma; Katsuyuki Miura; Shuichi Kaneko
Journal:  J Gastroenterol       Date:  2007-04-26       Impact factor: 7.527

7.  Trunk fat is associated with increased serum levels of alanine aminotransferase in the United States.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Gastroenterology       Date:  2010-01-11       Impact factor: 22.682

Review 8.  Strategies to rescue steatotic livers before transplantation in clinical and experimental studies.

Authors:  Qiang Liu; Maria-Louisa Izamis; Hongzhi Xu; Tim Berendsen; Martin Yarmush; Korkut Uygun
Journal:  World J Gastroenterol       Date:  2013-08-07       Impact factor: 5.742

9.  Treatment of Nonalcoholic Fatty Liver Disease.

Authors:  Suthat Liangpunsakul; Naga Chalasani
Journal:  Curr Treat Options Gastroenterol       Date:  2003-12

10.  Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease.

Authors:  Satoko Ohmi; Masafumi Ono; Hiroshi Takata; Seiki Hirano; Shogo Funakoshi; Yuichi Nishi; Kumiko Yoshimura; Eri Amano; Yoshio Terada; Toshiji Saibara; Shimpei Fujimoto
Journal:  Diabetol Metab Syndr       Date:  2017-09-05       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.